127 related articles for article (PubMed ID: 6546533)
1. Amsacrine (m-AMSA) in squamous cell carcinoma of the uterine cervix: a Southwest Oncology Group study.
Hilgers RD; Legha SS; Boutselis JG; Hannigan EV; Stephens RL; Tranum BL; Surwit E
Cancer Treat Rep; 1984 Feb; 68(2):443-4. PubMed ID: 6546533
[No Abstract] [Full Text] [Related]
2. Phase II trial of amsacrine in metastatic or locally recurrent squamous cell carcinoma from head and neck primaries: a Southwest Oncology Group study.
Witherspoon RP; Legha SS; Reimer RR; Talley RW; Stuckey WJ; Dixon DO; McCracken JD; Stephens RL; Oishi N
Cancer Treat Rep; 1984 Feb; 68(2):435-6. PubMed ID: 6546532
[No Abstract] [Full Text] [Related]
3. Phase II trial of AMSA in patients with advanced or recurrent squamous cell carcinoma of the cervix: a gynecologic oncology group study.
Bonomi P; Blessing JA; Sedlacek TV; Homesley HD; DiSaia PJ
Cancer Treat Rep; 1983 Feb; 67(2):197-8. PubMed ID: 6687445
[No Abstract] [Full Text] [Related]
4. Phase II trial of m-AMSA in hepatocellular carcinoma: a Southwest Oncology Group Study.
Bukowski RM; Legha S; Saiki J; Eyre HJ; O'Bryan R
Cancer Treat Rep; 1982 Aug; 66(8):1651-2. PubMed ID: 6286120
[TBL] [Abstract][Full Text] [Related]
5. Phase II study of amsacrine (m-AMSA) in advanced lymphomas: a Southwest Oncology Group study.
Weick JK; Jones SE; Ryan DH
Cancer Treat Rep; 1983 May; 67(5):489-92. PubMed ID: 6687839
[TBL] [Abstract][Full Text] [Related]
6. M-AMSA in disseminated prostatic carcinoma: a phase II study.
Drelichman A; Decker DA; Al-Sarraf M; Dhabuwala CB
Cancer Treat Rep; 1982 Nov; 66(11):1993-4. PubMed ID: 6897206
[No Abstract] [Full Text] [Related]
7. Phase II study of AMSA in lung cancer.
Samson MK; Fraile RJ; Baker LH; Cummings G; Talley RW
Cancer Treat Rep; 1981; 65(7-8):655-8. PubMed ID: 6265083
[TBL] [Abstract][Full Text] [Related]
8. Phase II trial of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) in patients with metastatic renal cell carcinoma.
Van Echo DA; Markus S; Aisner J; Wiernik PH
Cancer Treat Rep; 1980; 64(8-9):1009-10. PubMed ID: 6893810
[No Abstract] [Full Text] [Related]
9. Phase II trial of amsacrine (AMSA) in urinary bladder cancer.
Natale RB; Yagoda A; Blumenreich MS; Watson RC
Cancer Treat Rep; 1983 Apr; 67(4):391-2. PubMed ID: 6687836
[No Abstract] [Full Text] [Related]
10. Phase II evaluation of AMSA in patients with metastatic lung cancer.
Nichols WC; Eagan RT; Frytak S; Ingle JN; Creagan ET; Kvols LK
Cancer Treat Rep; 1980; 64(12):1383-5. PubMed ID: 6894104
[TBL] [Abstract][Full Text] [Related]
11. Mitoxantrone and advanced squamous cell carcinoma of the cervix: a Southwest Oncology Group Study.
Hilgers RD; Von Hoff DD; Stephens RL; Boutselis JG
Cancer Treat Rep; 1986 Apr; 70(4):527-8. PubMed ID: 3698047
[No Abstract] [Full Text] [Related]
12. Treatment of advanced colorectal carcinoma with AMSA.
Ferraro JA; Horton J; Weissman C; Ruckdeschel JC; O'Donnell M; Ludlum D
Cancer Treat Rep; 1981; 65(3-4):345-7. PubMed ID: 6894563
[TBL] [Abstract][Full Text] [Related]
13. Phase II evaluation of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) in patients with non-small cell lung cancer.
Casper ES; Gralla RJ; Kelsen DP; Natale RB; Sordillo P; Houghton A
Cancer Treat Rep; 1980; 64(2-3):345-7. PubMed ID: 6893294
[No Abstract] [Full Text] [Related]
14. m-AMSA and adenocarcinoma of the endometrium. A Southwest Oncology Group study.
Hilgers RD; Legha SS; Johnston GA; Alberts DS; Stephens RL; Tranum BL; Hannigan EV
Invest New Drugs; 1984; 2(3):335-8. PubMed ID: 6548984
[TBL] [Abstract][Full Text] [Related]
15. Phase II trial of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) in patients with metastatic hypernephroma.
Schneider RJ; Woodcock TM; Yagoda A
Cancer Treat Rep; 1980 Jan; 64(1):183-5. PubMed ID: 6892892
[No Abstract] [Full Text] [Related]
16. m-AMSA in epithelial carcinoma of the ovary. A Southwest Oncology Group study.
Hilgers RD; Legha SS; Panettiere FJ; Alberts DS
Am J Clin Oncol; 1983 Jun; 6(3):277-9. PubMed ID: 6687779
[TBL] [Abstract][Full Text] [Related]
17. Phase II evaluation of amsacrine (m-AMSA) in solid tumors, myeloma, and lymphoma: a University of Arizona and Southwest Oncology Group Study.
Ahmann FR; Meyskens FL; Jones SE; Bukowski RM; Saiers JH; Ryan DH; Costanzi J; Vaughn CB; Coltman CA
Cancer Treat Rep; 1983; 67(7-8):697-700. PubMed ID: 6688199
[TBL] [Abstract][Full Text] [Related]
18. Phase II trial of amsacrine in pancreatic carcinoma: a Southwest Oncology Group study.
Inamasu M; Oishi N; Chen T; Legha S; McCracken J; Balcerzak S; Stephens R; O'Bryan R; Rivkin SE; Costanzi JJ
Cancer Treat Rep; 1984 Nov; 68(11):1411-2. PubMed ID: 6548661
[No Abstract] [Full Text] [Related]
19. Meta AMSA (m-AMSA) in patients with advanced ovarian carcinoma.
Kearsley JH; Page JP; Levi JA; Woods RL; Tattersall MH; Fox RM; Coates AS
Aust N Z J Obstet Gynaecol; 1982 May; 22(2):107-9. PubMed ID: 6958247
[No Abstract] [Full Text] [Related]
20. Phase II evaluation of 4'-(9-acridinylamino)-methanesulfon-m--anisidine (AMSA) in patients with advanced head and neck cancers.
Ratanatharathorn V; Drelichman A; Sexon-Porte M; Al-Sarraf M
Am J Clin Oncol; 1982 Feb; 5(1):29-32. PubMed ID: 6896258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
